[Mononuclear cell reactions in the combined treatment of patients with a cutaneous melanoblastoma of the lower extremities].
Changes in lymphocyte and monocyte counts in peripheral blood of patients who had undergone combined treatment for malignant cutaneous melanoma of low extremities were evaluated. The posttreatment counts were compared with those for mononuclear cell infiltration of tumor stroma. Mononuclear cell levels in blood and in tumor stroma versus patients' survival time were analysed. A moderate correlation between lymphocyte and monocyte (macrophage) levels in tumor stroma, on the one hand, and survival time, on the other, was established.
D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007111:Immunity, Cellular; D007866:Leg; D007958:Leukocyte Count; D008297:Male; D008545:Melanoma / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D009000:Monocytes / Q000276:immunology*; D009367:Neoplasm Staging; D011184:Postoperative Period; D012878:Skin Neoplasms / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D013997:Time Factors
Reaktsii mononuklearov pri kombinirovannum lechenii bol'nykh melanoblastomoĭ kozhi nizhnikh konechnosteĭ.